Mergermarket: Cryoport Continues Opportunistic Acquisition Drive to Build Upon Current Markets
By Mintoi Chessa-Florea in London – editor of Mergermarket, an Acuris companyOriginally published by Mergermarket and re-published with author permission
December 01, 2021
By Mintoi Chessa-Florea in London – editor of Mergermarket, an Acuris companyOriginally published by Mergermarket and re-published with author permission
October 08, 2021
Logistics & Transportation Review features Cryoport Systems' Chief Operating Officer, Phil Wilson, on a critical and transparent conversation of technology changes coming up on active shipment...
August 17, 2021
Authority Magazine interviews Mark Sawicki, CEO of Cryoport Systems, on his expertise in the science, pharmaceutical and healthcare industry. Sawicki takes on his perspective of the current state of...
April 21, 2021
With the growing market of cell and gene therapy manufacturing, Cryoport's scalability in providing storage and logistics capabilities for these life-saving therapies are now more important than ever.
March 04, 2021
While the COVID-19 vaccine rollouts are excellent news, they will impact the pharma and biopharma supply chain. Cryoport Systems CEO Mark Sawicki outlines what to expect the rest of the year in a new
January 29, 2021
While the pandemic continues to disrupt many industries, including regenerative medicine, it’s not all bad news -- in fact, there are likely some bright spots ahead for the industry this year.
In an
December 03, 2020
Jerrell Shelton, Chief Executive Officer of Cryoport, Inc. recently participated in a live interview on Bloomberg, discussing the complexities and challenges of logistic vaccine distribution, as well...
December 02, 2020
By Joseph Harvey – editor of IHS Markit Animal Health (formerly Animal Pharm)Originally published by IHS Markit Animal Health and re-published with author permission
October 14, 2020
Mark Sawicki, Chief Executive Officer of Cryoport Systems, in collaboration with our strategic partners, Lonza and Vineti, published a new white paper featured in the peer-reviewed journal ...
September 30, 2020
The much-anticipated ISO 21973:2020 has arrived, supplying a set of guidelines and best practices for the transportation of cell and gene therapies. Cryoport’s experts played a role in developing...
July 17, 2020
The last few months have been unprecedented in world history. The pandemic that is gripping the world has spared no country, culture or corner, and it has highlighted the gaps in many companies’...
June 23, 2020
A new Contract Pharma article is all about Cryoport!
January 03, 2020
Commercial Officer Mark Sawicki brings more than a sales background to the company: He also holds a Ph.D. in biochemistry and has a distinguished career in global biopharmaceutical development.
...
December 04, 2019
A new article for Pharma Manufacturing breaks down the technology innovations that are changing cold chain logistics.
November 12, 2019
Cryoport is expanding its impact on regenerative medicine development and distribution via a new partnership with Lonza.
October 15, 2019
“The past year has seen Cryoport establish multiple collaborations and expansions of its offering,” says a new article in BioPharma-Reporter, “due to the booming cell and gene therapy space and the...
September 24, 2019
With just a handful of cell and gene therapies currently on the market, we’ve only seen the tip of the iceberg.
That’s how Cryoport’s Executive Director of Business Development, Ryan Carpentier,...
September 10, 2019
In a new article for Contract Pharma, Cryoport Executive Director of Business Development Ryan Carpentier explains the exciting new opportunities of CAR T-cell immunotherapy, which enables a...
September 10, 2019
New articles in Outsourcing Pharma and Pharmaceutical Commerce highlight the exciting benefits of the recently announced partnership between Cryoport and Vineti.
August 29, 2019
A new article in Life Science Leader chronicles the incredible achievements of Robert Hariri, M.D., Ph.D. The CEO of Celularity (a Cryoport-supported company) is also a neurosurgeon, a jet aviator, a...
August 14, 2019
A special supply-chain focused edition of Outsourcing-Pharma highlights Cryoport’s new patent-pending technology and excellent Q2 earnings report.
June 26, 2019
According to the well-known physics principle, an object in motion tends to stay in motion. That's been especially true at Cryoport over the past six months, as we’ve celebrated one big milestone...
April 22, 2019
Cryoport has experienced remarkable growth in the past year: the company opened facilities in Amsterdam and Livingston, N.J., expanded its animal health services, hired several new employees, and...
April 16, 2019
Keeping life-saving medical specimens viable as they traverse the world is no simple task—and Cryoport does this hundreds of times each day. Monitoring the temperature, orientation, and location of...
March 27, 2019
In recent interview with Technology Networks, Chief Commercial Officer Mark Sawicki discloses the importance of correctly transporting biological materials and how our best in class solutions support...
Americas • EMEA • APAC
Sales • +1 949.232.1900 | Support • +1 949.470.2300
©2021 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC